BioLargo Net Cash Flow 2010-2025 | BLGO

BioLargo net cash flow from 2010 to 2025. Net cash flow can be defined as the total change in cash for the company over the given period.
BioLargo Annual Net Cash Flow
(Millions of US $)
2024 $0
2023 $2
2022 $1
2021 $0
2020 $0
2019 $0
2018 $0
2017 $-1
2016 $0
2015 $2
2014 $0
2013 $0
2012 $0
2011 $0
2010 $0
2009 $0
Sector Industry Market Cap Revenue
Construction Engineering - Research & Development Services $0.053B $0.018B
BioLargo Inc. is a cleantech and life sciences innovator and engineering services solution provider. The company's core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs. BioLargo Inc. is based in WESTMINSTER, CA.
Stock Name Country Market Cap PE Ratio
Quanta Services (PWR) United States $57.740B 42.58
Alfa Laval AB (ALFVY) Sweden $18.062B 23.37
AECOM (ACM) United States $15.721B 22.99
Sterling Infrastructure (STRL) United States $9.108B 40.24
Fluor (FLR) United States $7.099B 20.42
Babcock Group (BCKIY) United Kingdom $6.831B 0.00
KBR (KBR) United States $6.393B 13.63
Amentum Holdings (AMTM) United States $6.263B 12.56
Arcadis (ARCAY) Netherlands $4.518B 0.00
VSE (VSEC) United States $3.229B 46.49
Vesuvius (CKSNY) United Kingdom $1.295B 0.00
TSS (TSSI) United States $0.719B 79.86
Chiyoda (CHYCY) Japan $0.505B 6.72
Magnera (MAGN) United States $0.409B 0.00
Mayville Engineering (MEC) United States $0.300B 15.11
Harris & Harris (TURN) United States $0.043B 0.00
Skyline Builders (SKBL) Hong Kong, SAR China $0.017B 0.00
SUs (SUGP) Hong Kong, SAR China $0.010B 0.00
SKK Holdings (SKK) Singapore $0.009B 0.00
WANG & LEE GROUP (WLGS) Hong Kong, SAR China $0.001B 0.00